Literature DB >> 3065242

Influenza subtype-specific IgA, IgM and IgG responses in patients on hemodialysis after influenza vaccination.

P Rautenberg1, I Teifke, T Schlegelberger, U Ullmann.   

Abstract

The isotype-specific antibody response to influenza vaccination in 36 patients undergoing chronic intermittent hemodialysis was analyzed by an influenza subtype-specific immunofluorescence test. The immune response was recorded at regular intervals over five months. On the basis of fourfold IgG titer rises as the classical parameter protection from infection was assumed to occur in more than 85% of healthy adults to each of the influenza antigens. In contrast, about 70% of the patients on hemodialysis had responded to influenza A H1N1 and H3N2 vaccines while only 50% of the patients on hemodialysis had responded to influenza B antigen. However, patients showed decreased rates and lower peak responses in IgA, IgM and IgG antibodies to influenza A and B antigens. Probably as a result of the underlying renal disease the different kinetics of antibody responses and the lower influenza specific immunoglobulin levels resulted in lower seroconversion rates in hemodialysis patients compared to those in healthy volunteers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3065242     DOI: 10.1007/bf01644539

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  16 in total

1.  Value of booster immunisation with influenza vaccine in patients undergoing haemodialysis.

Authors:  D J Versluis; W E Beyer; N Masurel; W Weimar; P Kramer; P P Diderich
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-07

2.  Monovalent influenza A(H1N1) vaccine, 1986-1987.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-08-15       Impact factor: 17.586

3.  Prevention and control of influenza.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-05-23       Impact factor: 17.586

4.  Immunogenicity of inactivated influenza virus vaccine in chronic renal failure.

Authors:  M C Jordan; W E Rousseau; G E Tegtmeier; G R Noble; R G Muth; T D Chin
Journal:  Ann Intern Med       Date:  1973-12       Impact factor: 25.391

5.  Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine.

Authors:  D J Versluis; W E Beyer; N Masurel; G J Wenting; W Weimar
Journal:  Transplantation       Date:  1986-10       Impact factor: 4.939

Review 6.  Immunity to influenza in man.

Authors:  R B Couch; J A Kasel
Journal:  Annu Rev Microbiol       Date:  1983       Impact factor: 15.500

7.  Antibody responses to influenza vaccination in patients with chronic renal failure.

Authors:  E O Osanloo; B S Berlin; S Popli; T S Ing; J E Cummings; V C Gandhi; W P Geis; J E Hano
Journal:  Kidney Int       Date:  1978-12       Impact factor: 10.612

8.  Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

Authors:  B R Murphy; D L Nelson; P F Wright; E L Tierney; M A Phelan; R M Chanock
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines.

Authors:  B R Murphy; E L Tierney; B A Barbour; R H Yolken; D W Alling; H P Holley; R E Mayner; R M Chanock
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysis.

Authors:  J S Oxford; R Yetts; G C Schild
Journal:  J Hyg (Lond)       Date:  1982-04
View more
  9 in total

1.  Immunization of elderly volunteers with the 1988-89 inactivated whole influenza vaccine: assessment of antibody responses by haemagglutination inhibition and single radial haemolysis tests.

Authors:  A M Iorio; T Zei; M Neri; L Campitelli; M R Castrucci; I Donatelli
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

Review 2.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

3.  Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.

Authors:  David T Gilbertson; Kenneth J Rothman; Glenn M Chertow; Brian D Bradbury; M Alan Brookhart; Jiannong Liu; Wolfgang C Winkelmayer; Til Stürmer; Keri L Monda; Charles A Herzog; Akhtar Ashfaq; Allan J Collins; James B Wetmore
Journal:  J Am Soc Nephrol       Date:  2019-01-24       Impact factor: 10.121

4.  Cost-effectiveness of adjuvanted versus nonadjuvanted influenza vaccine in adult hemodialysis patients.

Authors:  Bruce Y Lee; Randy M Stalter; Kristina M Bacon; Julie H Y Tai; Rachel R Bailey; Shanta M Zimmer; Michael M Wagner
Journal:  Am J Kidney Dis       Date:  2011-03-10       Impact factor: 8.860

Review 5.  Secondary Immunodeficiency Related to Kidney Disease (SIDKD)-Definition, Unmet Need, and Mechanisms.

Authors:  Stefanie Steiger; Jan Rossaint; Alexander Zarbock; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2021-12-14       Impact factor: 10.121

6.  Influenza subtype-specific immunoglobulin A and G responses after booster versus one double-dose vaccination in hemodialysis patients.

Authors:  P Rautenberg; D Proppe; A Schütte; U Ullmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

7.  Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis.

Authors:  Moustafa Moustafa; George R Aronoff; Chandra Chandran; Jonathan S Hartzel; Steven S Smugar; Claude M Galphin; Lionel U Mailloux; Elizabeth Brown; Mark J Dinubile; Nicholas A Kartsonis; Dalya Guris
Journal:  Clin Vaccine Immunol       Date:  2012-07-25

Review 8.  Effects of parathyroid hormone on immune function.

Authors:  Abdallah Sassine Geara; Mario R Castellanos; Claude Bassil; Georgia Schuller-Levis; Eunkue Park; Marianne Smith; Michael Goldman; Suzanne Elsayegh
Journal:  Clin Dev Immunol       Date:  2010-09-16

9.  Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3-5 months follow-up.

Authors:  Iddo Z Ben-Dov; Yonatan Oster; Keren Tzukert; Talia Alster; Raneem Bader; Ruth Israeli; Haya Asayag; Michal Aharon; Ido Burstein; Hadas Pri-Chen; Ashraf Imam; Roy Abel; Irit Mor-Yosef Levi; Abed Khalaileh; Esther Oiknine-Djian; Aharon Bloch; Dana G Wolf; Michal Dranitzki Elhalel
Journal:  J Nephrol       Date:  2022-01-06       Impact factor: 3.902

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.